Showing 8,221 - 8,240 results of 20,793 for search '"Therapy"', query time: 0.11s Refine Results
  1. 8221

    Comparative Analysis of the Influence of Selected Physical Factors on the Level of Pain in the Course of Temporomandibular Joint Disorders by Łukasz Kopacz, Żaneta Ciosek, Helena Gronwald, Piotr Skomro, Roman Ardan, Danuta Lietz-Kijak

    Published 2020-01-01
    “…Each group consisted of 30 people and was subjected to separate therapies in which LED light therapy with electromagnetic field (MLT) and cryotherapy (CT) were applied. …”
    Get full text
    Article
  2. 8222

    Adalimumab for endoscopic and histopathological mucosal healing in paediatric patients with moderate to severe Crohn’s disease by Edyta Szymanska, Maciej Dadalski, Wieslawa Grajkowska, Sylwia Szymanska, Maciej Pronicki, Jaroslaw Kierkus

    Published 2016-12-01
    “…Aim : To assess the impact of biological therapy with ADA on both endoscopic and histopathological MH in paediatric patients with CD. …”
    Get full text
    Article
  3. 8223

    Two-Stage Treatment of Enterocutaneous Fistulas by V. Yu. Struchkov, S. V. Berelavichus, E. A. Akhtanin, D. S. Gorin, M. V. Dvukhzhilov, A. A. Goev, A. I. Burmistrov, P. V. Markov, A. G. Kriger

    Published 2023-11-01
    “…Eighty-eight patients with intestinal fistulas underwent a two-stage treatment, including: the first stage — multicomponent therapy, the second stage — reconstructive surgery. …”
    Get full text
    Article
  4. 8224

    GsMTx-4 combined with exercise improves skeletal muscle structure and motor function in rats with spinal cord injury. by Xin Zhang, Xinyu Liu, Qianxi Li, Chenyu Li, Xinyan Li, Jinghua Qian, Jianjun Li, Xuemei Li

    Published 2025-01-01
    “…Exercise training is a conventional physical therapy after SCI, but exercise intervention alone may have limited efficacy in reducing secondary injury and promoting nerve regeneration and functional remodeling. …”
    Get full text
    Article
  5. 8225
  6. 8226

    Clinical features, treatment, and prognosis of secukinumab-induced inflammatory bowel disease by Ronghui Li, Haibo Lei, Chunjiang Wang, Xiang Liu

    Published 2025-01-01
    “…Upon the diagnosis of IBD, secukinumab should be discontinued, and systemic steroid therapy should be initiated. Patients who do not respond or experience a relapse should be considered for immunosuppressive therapy.…”
    Get full text
    Article
  7. 8227
  8. 8228

    Human neural stem cell–derived extracellular vesicles protect against ischemic stroke by activating the PI3K/AKT/mTOR pathway by Jiayi Wang, Mengke Zhao, Dong Fu, Meina Wang, Chao Han, Zhongyue Lv, Liang Wang, Jing Liu

    Published 2025-11-01
    “…Human neural stem cell–derived extracellular vesicles exhibit analogous functions to their parental cells, and can thus be used as substitutes for stem cells in stem cell therapy, thereby mitigating the risks of stem cell therapy and advancing the frontiers of stem cell–derived treatments. …”
    Get full text
    Article
  9. 8229

    Thoracic Endovascular Aortic Repair for Blunt Thoracic Aortic Injury: A Report of Three Cases in Which Surgeries Were Performed at Different Timings by Yohei Kawatani, Hirotsugu Kurobe, Yoshitsugu Nakamura, Yuji Suda, Takaki Hori

    Published 2018-01-01
    “…The timing of the operation and therapeutic option, including conservative therapy, should be decided for each patient.…”
    Get full text
    Article
  10. 8230
  11. 8231

    Occlusion Outcomes in Unilateral Amblyopia Types: A Longitudinal and Interventional Study in Children from the Marrakech-Safi Region by Mustapha Jaouhari, Chaimae El Harrak, Farida Bentayeb, Youssef El Merabet

    Published 2024-12-01
    “…Children underwent amblyopia treatment with standard occlusion therapy and were followed monthly, for eight visits. …”
    Get full text
    Article
  12. 8232

    Health Economic Analysis of Two-Layer Bandage System for Treatment of Chronic Venous Insufficiency by Peter J. Mallow

    Published 2023-08-01
    “…**Background:** Compression therapy is the gold standard for the treatment of chronic venous insufficiency (CVI). …”
    Get full text
    Article
  13. 8233

    Deciphering sepsis: transforming diagnosis and treatment through systems immunology by Robert E. W. Hancock, Andy An, Claudia C. dos Santos, Amy H. Y. Lee

    Published 2025-01-01
    “…., cellular reprogramming) that could inform early therapy. Sepsis patients can now be categorized into “endotypes” based on unique immune dysfunction mechanisms corresponding to varying severity and mortality rates, raising the prospect of endotype-specific diagnostics and patient-specific immune-directed therapy. …”
    Get full text
    Article
  14. 8234

    Effects of Severe Hypoxia on Bone Marrow Mesenchymal Stem Cells Differentiation Potential by Claudia Cicione, Emma Muiños-López, Tamara Hermida-Gómez, Isaac Fuentes-Boquete, Silvia Díaz-Prado, Francisco J. Blanco

    Published 2013-01-01
    “…The interests in mesenchymal stem cells (MSCs) and their application in cell therapy have resulted in a better understanding of the basic biology of these cells. …”
    Get full text
    Article
  15. 8235

    Canadian Thoracic Society Recommendations for Management of Chronic Obstructive Pulmonary Disease – 2003 by Denis E O’donnell, Shawn Aaron, Jean Bourbeau, Paul Hernandez, Darcy D Marciniuk, Meyer Balter, Gordon Ford, Andre Gervais, Roger Goldstein, Rick Hodder, Francois Maltais, Jeremy Road

    Published 2003-01-01
    “…Long acting anticholinergics and beta2-agonist inhalers should be prescribed for patients who remain symptomatic despite short-acting bronchodilator therapy. Inhaled steroids should not be used as first line therapy in COPD, but have a role in preventing exacerbations in patients with more advanced disease who suffer recurrent exacerbations. …”
    Get full text
    Article
  16. 8236

    Exosome-Derived Noncoding RNAs as a Promising Treatment of Bone Regeneration by Bei Yin, Qingge Ma, Chenghao Song, Lingyi Zhao, Fanyuan Yu, Chenglin Wang, Yu Shi, Ling Ye

    Published 2021-01-01
    “…While mesenchymal stem cell (MSC) therapy may address these limitations, growing researches have demonstrated that the effectiveness of MSC therapy depends on paracrine factors, particularly exosomes. …”
    Get full text
    Article
  17. 8237

    Emotional and physical experiences of people with neovascular age-related macular degeneration during the injection process in Germany: a qualitative study by Oliver Zeitz, Martina Breuning, Christine Holmberg, Christian Wolfram, Anne Thier

    Published 2022-06-01
    “…Objectives In order to better understand the continued barriers to the provision of vascular endothelial inhibitor therapy, this study aims to investigate patients’ experiences with neovascular age-related macular degeneration (nvAMD) in Germany during the injection process and how they deal with it.Design and participants This analysis is part of the qualitative arm of a wider mixed-methods study. …”
    Get full text
    Article
  18. 8238

    Gene Expression Profiling in Lungs of Chronic Asthmatic Mice Treated with Galectin-3: Downregulation of Inflammatory and Regulatory Genes by Esther López, M. Paz Zafra, Beatriz Sastre, Cristina Gámez, Carlos Lahoz, Victoria del Pozo

    Published 2011-01-01
    “…In a previous study, we demonstrated that treatment of chronic asthmatic mice with gene therapy using plasmid encoding galectin-3 (Gal-3) led to an improvement in Th2 allergic inflammation. …”
    Get full text
    Article
  19. 8239

    Severe Postpartum Hemorrhage from Uterine Atony: A Multicentric Study by Carlos Montufar-Rueda, Laritza Rodriguez, José Douglas Jarquin, Alejandra Barboza, Maura Carolina Bustillo, Flor Marin, Guillermo Ortiz, Francisco Estrada

    Published 2013-01-01
    “…Maternal deaths were associated with inadequate transfusion therapy. Conclusions. In all patients with severe hemorrhage and subsequent hypovolemic shock, the most important therapy is intravascular volume resuscitation, to reduce the possibility of target organ damage and death. …”
    Get full text
    Article
  20. 8240

    Cost–consequence analysis of COPD treatment according to NICE and GOLD recommendations compared with current clinical practice in the UK by Jennifer K Quint, Helene Vioix, Toby Capstick, Sue Langham, Jennifer Cook, Antony Wright, Shamika de Silva

    Published 2022-06-01
    “…Savings were achieved overall despite a small increase in the rate of exacerbations due to the redistribution of certain patients currently undergoing triple inhaled therapy to therapies not containing inhaled corticosteroids.Conclusion Redistribution of patients with COPD from current clinical practice to treatment according to published recommendations would provide substantial cost savings over the first year.…”
    Get full text
    Article